DIADEMA PARTNERS LP
Q3 2025 13F Holdings
- Locationmorristown, NJ
- Num holdings
130
- Value ($000)
$390,972
- Date Filed 11/14/2025
- Form type13F-HR
- CIK 0002026172
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
UNIQURE NV | SHS | N90064101 | $17.51M | 5 % | 300,000 | put | |
R REGENERON PHARMACEUTICALS | COM | 75886F107 | $16.96M | 4 % | 30,160 | ||
S SPDR S&P 500 ETF TR | TR UNIT | 78462F103 | $13.32M | 3 % | 20,000 | put | |
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | $13.18M | 3 % | 100,000 | call | |
SOLENO THERAPEUTICS INC | COM | 834203309 | $11.99M | 3 % | 177,330 | ||
B BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | $11.53M | 3 % | 212,877 | ||
V VIKING THERAPEUTICS INC | COM | 92686J106 | $10.65M | 3 % | 405,100 | call | |
A AGIOS PHARMACEUTICALS INC | COM | 00847X104 | $8.92M | 2 % | 222,100 | call | |
R AVIDITY BIOSCIENCES INC | COM | 05370A108 | $8.72M | 2 % | 200,100 | call | |
I INCYTE CORP | COM | 45337C102 | $8.48M | 2 % | 100,000 | call |
Rows Per Page
10
- 10
- 50
- 100